You prove my point in another post of mine @Mom88. Biotechs have been sold down horrendously over the last few years and will always be able to raise money if they have viable IP. I can see Osteopore is just one of many biotechs which may rise substially in the future once their products are approved.
Ann: Prospectus for Renounceable Rights Issue, page-34
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
